HER2 Positive Breast Cancers with Progression

被引：0
|
作者：
Solanki, Malvika [1 ]
Chitambar, Christopher [2 ]
Jorns, Julie [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Med Coll Wisconsin, Affiliated Hosp, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
259
引用
收藏
页数：3
相关论文
共 50 条
  • [41] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] CLINICOPATHOLOGICAL ANALYSIS OF THE RISK FACTORS OF DISEASE PROGRESSION IN HER2 POSITIVE BREAST CANCER PATIENTS
    Huszno, Joanna
    Nowara, Elzbieta
    BREAST, 2013, 22 : S47 - S47
  • [43] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen Awad
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [44] Accurate modeling of HER2 positive breast cancer disease progression with a biophysical modeling software
    Pfeiffer, John
    Foley, Tim
    Braun, Eduardo
    Antony, Anu
    Munn, Lance
    Peterson, Joseph R.
    Cole, John A.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Personalized medicine for HER2 positive breast cancer
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Characterization of HER2 positive breast cancer in Tunisia
    Yaiche, R.
    Houcine, Y.
    Saidi, E.
    Saadallah, F.
    Kamoun, S.
    Meddeb, K.
    Driss, M.
    VIRCHOWS ARCHIV, 2024, 485 : S210 - S210
  • [47] Delayed chemotherapy in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    CANCER RESEARCH, 2020, 80 (04)
  • [48] Treatment of HER2 positive breast cancer patients
    Matos, Erika
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
  • [49] HER2 POSITIVE BREAST CANCER - BIOLOGY AND RESISTANCE
    Penault-Llorca, Frederique
    BREAST, 2019, 48 : S31 - S31
  • [50] Luminal B breast tumors are not HER2 positive
    Rohit Bhargava
    David J Dabbs
    Breast Cancer Research, 10
12345